Multimodal salvage therapy for locally advanced esophageal cancer recurrence after failed post-ESD surveillance: a case report - Summary - MDSpire

Multimodal salvage therapy for locally advanced esophageal cancer recurrence after failed post-ESD surveillance: a case report

  • By

  • Mengzhi Cheng

  • Henghui Bian

  • Xuhua Cai

  • Jianbin Zhang

  • July 10, 2026

  • 0 min

Share

Objective:

To illustrate the consequences of inadequate postoperative surveillance following endoscopic submucosal dissection (ESD) for early esophageal squamous cell carcinoma (ESCC) through a case study and to present a successful multimodal salvage treatment.

Approach:
  • Patient Case: A 66-year-old man underwent ESD for early ESCC but was lost to follow-up. He returned 17 months later with locally advanced recurrence and received a comprehensive salvage treatment.
  • Treatment Protocol: The patient received neoadjuvant chemoimmunotherapy followed by radical transthoracic esophagectomy and adjuvant therapy.
Key Findings:
  • The patient experienced a dramatic progression to locally advanced disease due to loss to follow-up after ESD.
  • Neoadjuvant chemoimmunotherapy led to marked regression of the tumor and lymph nodes.
  • Final pathology post-surgery confirmed ypT2N0M0 disease, and the patient remained disease-free at the last follow-up in September 2025.
Interpretation:

This case highlights the critical importance of rigorous postoperative surveillance following ESD to prevent progression to advanced disease.

Limitations:
  • The case is a single patient report, limiting generalizability.
  • Financial constraints affected the patient's access to certain diagnostic procedures.
Conclusion:

Timely multimodal salvage strategies can offer the possibility of long-term survival even after surveillance failure.

Original Source(s)

Related Content